Dr.StellaNowicki’sCurriculumVitae07/01/2015,Pg.1of49

NAME: StellaNowicki,MD,DDS DATE:July,2015

PRESENTPOSITIONANDADDRESS:

Professor, DepartmentMicrobiologyandImmunology09/2005-present

Tenure, MeharryMedicalCollege07/2008-07/2018

Director

KeyLeader

CollaborationsandPartnershipsMeharryTranslationalResearchCenter(MeTRC)2010-present

ResearchCenterinMinorityInstitution(RCMI)Network07/2013-2018

MeharryMedicalCollege,1005Dr.D.B.Todd,Jr.,Blvd.,Nashville,TN37208

BIOGRAPHICAL:

PLACEOFBIRTH: Slupsk,PolandCITIZENSHIP: U.S.CitizenMARITALSTATUS: MarriedHOMEADDRESS: 114GovernorsWay

Brentwood,TN37027-8932

EDUCATION:

MedicalSchool MedicalSchool,DentalBranchGdanskUniversity,Poland,MDandDoctorofDentalSurgery(DDS)10/1977-10/1983

Postdoctoral HelsinkiUniversity,FinlandScholarshipinOralMicrobiology 6/1984-6/1985

Postdoctoral PostdoctoralFellowship,ResearchAssociateIDepartmentofMicrobiologyBaylorCollegeofMedicine,HoustonTX 6/1986–12/1989

Postdoctoral PostdoctoralFellowship,ResearchAssociateII

DepartmentofImmunology BaylorCollegeofMedicine,HoustonTX 1/1990–10/1991PROFESSIONALANDTEACHINGEXPERIENCE:

A. UNIVERSITYAPPOINTMENTS:

1. ResearchAssociateII,MarineBiomedicalInstitute,UniversityofTexasMedicalBranch(UTMB) 1991

2. JuniorFaculty-ResearchInstructor,Ob/Gyn,UTMB 1992-1993

3. AssistantProfessor,MicrobiologyandImmunology,UTMB 9/1993-9/2001

4. AssistantProfessor,Ob/Gyn,UTMB 9/1993-9/2001

5. AssociateProfessor,HeadofExperimentalLaboratory,DivisionofInfectiousDiseases,Ob/Gyn,UTMB 9/2001-9/2005

6. AssociateProfessor,MicrobiologyandImmunology;UTMB 9/2001-9/2005

7. AssociateProfessor,SealyCenterforVaccineDevelopment;UTMB 9/2001-9/2005

8. EndowedProfessor,OB/GYN,MMC 9/2005-9/2009

9. ProfessorMicrobiologyandImmunology,MMC 9/2005-present

10. FirstScientificDirector,CenterforWoman’sHealthResearch,MMC 9/2005-6/2007

11. DirectorforCollaborationsandPartnerships,MeTRC/NIH,05/2010-05/2014

B. SUPERVISORYRESPONSIBILITIES:Preceptorof42fellowsandstudents.

1. MedicalStudent:GregorySchulmeierImmunologyLab,BaylorCollegeofMedicine;1991.

2. PostdoctoralTraining:GustavoFlores,Ph.D.,Bacteriology,Ob/Gyn,UTMB;1993-1994.

3. HighSchoolStudentinSummerResearchProgram;KristopherHarris;1993.

4. ScienceFairProject;KristopherHarris;1993-1994.5. PostdoctoralFellowship;AnilKaul,M.D.;1993-1996.6. PostdoctoralTraining:PrashanthRam,M.D.,Bacteriology,Immunology

andMolecularBiology,Ob/Gyn;1994-1996.7. PostdoctoralTraining:RashmiKaul,Bacteriology;Ob/Gyn;1995-1996.8. PredoctoralTraining,SandhyaRam,B.S.,Bacteriology,Immunology;1994-1996.9. PostdoctoralTraining:AndrzejSkarpetowski,M.D.,Ob/Gyn;1995-1996.10. UndergraduateTraining:EdytaPawelczyk;1995.11. ResearchAssociate:AudreyHart;1996-2005.12. GraduateStudent:KhoaNguyen;1997-2000.13. MedicalStudent:RexTrevorRussell;1997-1998.14. MedicalStudent:AlexGordon;1997.15. HighSchoolStudentSummerResearchProgram:KeiraScanks;1998.16. UndergraduateA&MStudent:EricWilder;1997-1998.17. PostdoctoralTraining:MargaretDas,Ph.D.;1998-2002.18. UndergraduateStudentSharonMcConley–SummerResearchProgram;1999.19. HighSchoolStudentAmandaLampton-SummerResearchProgram;1999.20. MedicalStudent:MichaelHold;2001-2002.21. MedicalStudent:ErikB.Motsenbocker;2002-2003.22. GraduateStudent:JenniferCrawford;2002-2003.23. GraduateStudent:RafiaHasan,Microbiology;1998-2004.24. GraduateStudent:EdytaPawelczyk;UTMB,2000-2004.25. LesleighLee;GraduateStudentatMeharryMedicalCollege:200626. Ob/GynResidentatMeharryMedicalCollege:Dr.KeshaRobertson; 2006-Present27. RicardoAbahka,DentalStudentatMMC;summer200728. ShelaneHill,DentalStudentatMMC;summer200729. JiibrilPalmer,MedicalStudentatMMC;Nov2007–present

30. HokaNyanda,ResidentatMedicalUniversityofSouthCarolina,Nov2007–present31. CandiceJohnson,GraduateStudentatMMC,Jan–February200832. Keri McLean, Graduate Student at MMC, Jan – February 2008 33. Candice Johnson, Graduate Student at MMC, 2008-2009 34. KelsiHurt,GraduateStudentatMMC,2009-201035. SamuelPellom,GraduateStudentatMMC,200936. Rajbir Singh, MD –Postdoctoral Fellow, MMC, June 2010-2014 37. Tanu Rana, PhD-Postdoctoral Fellow, MMC, August 2010-2015 38. Nicole Pace, MMC, MD student June -August 2011 (8 weeks) 39. Emon Felton, MMC, MD student June –August 2012 (8weeks)

40. Nadia Winston, MMC, MS student January-May 2012 ( 22weeks)41. Mariella Ntamatungiro, MMC, MD student June –August 2013 (8 weeks)

42. Ariel Ansley, MMC, MD student June-August 2013 (8 weeks)43. Jessica Sutton, MMC/Vanderbilt, PhD student March 2014-present

RESEARCHACTIVITIES:

A. AREASOFRESEARCH:

I. Theprimaryobjectiveofourlaboratoryisinfectionandimmunologyofuro-genitaltract:1. Immunologyofpretermlabor2. Racialdisparitiesinpretermlabor3. E.coliinfectionandpretermlabor4. Lowbirthweight,uterineinfectionandnitricoxide5. VirulencemechanismofNeisseriagonorrhoeaeinPelvicInflammatory

Disease(PID)andsepticemia6. AnimalmodelofgonococcalinfectionsupportedbyJ.Sealy

Foundation.(S.Nowickietal.,InfectImmun.63:4790-94,1995)U.S.PatentNo.5,824,480

7. NoveldiagnosticmethodforgonococcalPIDsupportedbyJ.McLaughlinFoundation.(S.Nowickietal.,InfectImmun.65:2094-99,1997)U.S.Patent1998

8. NovelmicrobialvirulencemechanismofPIDandDGIstrainsofN.gonorrhoeaethatbindhumancomplementC1q(partofhumandefensesystem)toincreasebacterialvirulence(survivalandattachment)

9. VaccinedevelopmentforgonococcalPID.(patent)10. E.colipyelonephritisandpretermlabor(pastgrantR012002-2007)11. Cardiovasculardisease(grant2006-2008)12. Endometriosis(activeR01grantMay2007–May2012)13. PeriodontalDiseaseandPTL(inprogress)

II. StudyinCollaboration

1. MolecularmechanismofClqdependentvirulenceofN.gonorrhoeae.2. ComplementClqsupportdevelopmentoffetalsepticemiabychallenging

pregnantratswithN.gonorrhoeae.3. VaccinedevelopmentforgonococcalPID,andsepticemiaidentification

andpurificationofC1qbindingantigensofN.gonorrhoeae.CollaborationwithDr.S.MorseDirectorofSTDatC.D.C.Atlanta,GA.

4. InfluenceofhostfactorC1qonN.gonorrhoeaesurvival,adhesion,invasionanddissemination.

5. UropathogenicE.coli.CollaborationwithDr.BogdanNowickiandhislaboratory.

6. HormonalinfluenceonbacterialinfectionCollaborationwithDr.ManubaiNagamani,ProfessorOb/GynDepartment,UTMB.

7. Gonococcaltransferrinbindingproteins.CollaborationwithDr.FredSparling,Professor,DepartmentofMicrobiology,ChapelHill,UniversityofNorthCarolina.

8. DAFexpressioninmalignancy.CollaborationwithDr.B.Nowicki,AssociateProfessor,DepartmentofOb/Gyn,UTMBandDr.ManubaiNagamani,Professor,DepartmentofOb/Gyn,UTMB.

9. Infectionduringpregnancyandnitricoxide.CollaborationwithDr.ChandraYallampalli,Professor,Ob/GynDepartment,UTMB.

10. Gonococcalserumresistanceandcomplementactivation,CollaborationwithDr.PeterRice,Professor,Director,BostonUniversity.

11. ComplementbindingtoN.gonorrhoeae.CollaborationwithDr.SanjayRam.AssistantProfessor,BostonUniversity.

12. DAFexpressioninpretermlabor.13. PretermdeliveryandTLR4.

14. Alzheimer’sDisease.15. BiochemistryofE.coliDr.fimbriae,collaborationwithDr.JosefKur,

ProfessorGdansk,University.16. Ob/GynResidentDr.KeshaRobertson–ResearchwithDr.Witty–

Collaboration.17. “PeridontalDiseaseasaRiskFactorforPTLMolecularMechanism”

CollaborationwithPauletteTempro,DDS.18. “PeridontalDiseaseasaRiskFactorforPTLMolecularMechanism”

CollaborationwithPauletteTempro,19. CD55inEndometriosis,collaborationwithDr.KevinOsteen,Vanderbilt

University

III. BackgroundandSignificance.1. PID-majorcomplicationofgenitaltractcausedbyN.gonorrhoeaeand

ChlamydiaTrachomatis.Affectsyoungwomeninthereproductiveage.Majorriskfactorinfertility,ectopicpregnancyandchronicpain.Increase(7times)riskforHIVtransmission.

2. Urinarytractinfection(UTI)isariskfactorforpretermlabor,lowbirthweightandforendstagerenaldisease.

3. PretermLabor4. CardiovascularDiseaseinWomen5. Endometriosis

GRANTSUPPORT CURRENT(4):NIH/U54 RR-01 Adunyah (PI) 07/1/2014-06/30/2019 Meharry Clinical and Translational Research Center (MeTRC) The goal is to establish a research center in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR) Budget: $17,000,000.00 Role: Director for Collaborations and Partnerships (S. Nowicki) RCMI Translational Research Network (RTRN) Drew University, California Funding: NIH/NCRR; 07/1/2015-06/30/2019; Keith Norris-PI Total Budget: $5,000,000.00 Budget: $0 Role: RTRN Liaison (S. Nowicki) CD55, vitamin D, and race in preterm labor; Funding: NIH- MeTRC Big Science; 01/15/2012- 05/01/2015; PI S. Nowicki Budget: $200,000.00 Role: PI (S. Nowicki) T32 NIH NHLBI F. Villalta (PI) 07/01/2014-06/30/2019 Cardiovascular Biology The goal of the project is to provide Cardiovascular training program for Meharry Medical College students in graduate school Role: Faculty Advisor (S. Nowicki)

Recent(10): 1. 5 U54 RR026140-01 Adunyah (PI) 09/30/2009-

06/30/2014 Meharry Clinical and Translational Research Center (MeTRC) The goal is to establish a research center in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR)

Budget: $21,000,000.00 Role: Director for Collaborations and Partnerships (S. Nowicki) 2. Title: ThePreventionofCardiovascularDiseaseinWomen Staff: PI:S.Nowicki Date: 09/2006–03/2010; Funding: FannieE.RippelFoundation;$150,000

2.Title:Infection and Fetal Growth Restriction; Budget: Staff: Co-PI; Yallampalli-PI Date: 08/2004-09/2011

Funding:NIH, R01; $1,125,000.00;

3. Title: CD55,Infection,andRaceinPretermDelivery. Staff: PI:S.Nowicki Date: 09/2004-09/2009; Funding: NIHR011R01HD41687-01;

4.Title:LossofComplementProtectiveCD55ExpressionStaff:PI:K.Osteen(VU)andPI:S.Nowicki(MMC),Sub-awardwithVanderbiltUniversity:S.Nowicki

($1,100,000.00/5y)Date:05/2007-04/2013Funding: NIH/NICHD:R011R01HD055648-01;$2,600,000.00

6. “Identification of DAF (CD55) Residues that Facilitate Invasion and Intracellular Survival of the Gestational Pathogen Dr+ E. coli” in 2012. Vanderbilt's Institute for Clinical and Translational Research (VICTR) grant Awarded $2000

7. RCMI Translational Research Network (RTRN) Drew University,

California Funding: NIH/NCRR; 07/30/2009-06/30/2014; Keith Norris-PI Total Budget: $5,000,000.00 Budget: $115,500.00 Role: RTRN Liaison (S. Nowicki)

8. “Microarray profiling of microRNAs expressed in HeLa cells/ECC1 cells upon Dr E. coli infection” in 2011. Vanderbilt's Institute for Clinical and Translational Research (VICTR) grant Awarded $2000

9. “Serum reproductive hormone and CD55 levels in preterm labor” 07/11

Vanderbilt's Institute for Clinical and Translational Research (VICTR) grant Awarded $2000

10. T32 NIH NHLBI F. Villalta (PI) 07/01/2009-06/30/2014 Cardiovascular Biology The goal of the project is to provide Cardiovascular training program for Meharry Medical College students in graduate school Role: Faculty Advisor (S. Nowicki)

PASTGRANTSUPPORT(12):

1. Title: RoleofBacterialLectinsinKidneyDiseaseStaff: Co-InvestigatorDate:1991-1995Funding:NIHDK42029;$1,155,562.00

2. Title: RoleofBacterialLectinsinKidneyDiseaseStaff:Co-InvestigatorDate:1996-2000Funding:NIH2R01DK42029-04A2;$1,096,416.00

3. Title: MolecularInteractionBetweenDAFandEscherichiacoliDrAdhesinastheFirstStepofInfectioninPyelonephritisandDiarrheaStaff:Co-InvestigatorDate:1997–1998Funding:SealyCenterforStructureBiology:$10,000.00

4. Title: ContributionoftheDraGenestotheInterstitialTropismof

UropathogenicEscherichiacoliBearingDrAdhesinStaff:Co-mentorforRangarajSelvarangan,GraduateStudentDate:1997–1999Funding:McLaughlinFellowship:$96,000.00

5. Title: UTMB-WRHRCareerDevelopmentCenterofExcellence

Staff: Co-MentorofMDfellowsDate: 1998-2003Funding: NIHofchildhealth&humandevelopmentH/1K12HD01269-

04;$1,989,409.00

6. Title: MolecularCharacterizationofDraEDomainsthatFacilitateBinding,InvasionaRenalTissueTropismofUropathogenicEscherichiacoli.

Staff: SponsorforM.Das,PhD(postdoc)Date: 2000-2002Funding:McLaughlinFellowshipFund;$125,964.00

7. Title: The Interaction of Complement C3 Convertase, and its Sub-Units,withDAF(CD55)Staff: Co-InvestigatorDate: 2000-2002Funding:JohnSealyResearchDevelopmentAward;$70,000.00

3. Title: Alzheimer’sDiseaseVaccineStaff: PI–S.NowickiDate: 06/01/01–06/01/02Funding:SealyCenteronAging;$12,000.00

9. Title: CD55,Infection,andRaceinPretermDelivery.Staff: Co-PIS.Nowicki,PI–B.Nowicki,Date: 2001-2005Funding: NIH/R011R01HD41687-01;$1,490,000.00

10.Title: DAF/TLR4RatiointheUTI-mediatedPretermLabor Staff: PI:EPawelczyk,Sponsors:B.NowickiandS.Nowicki Date: 9/2004–8/2005 Funding: JamesW.McLaughlinIntramuralGrants;$96,000.0011.Title: LowBirthWeight,Uterine,InfectionandNitricOxide Staff: PI:CYallampalli,Co-I:S.Nowicki,B.Nowicki,andM.Nagamani Date: 2002-2008

Funding: NIHR01HD42069-01;$1,490,00012. Title: MeharryRCMIPrograminWomen’sHealthResearch

Staff: PI:JamesG.Townsel ScientificDirectoroftheCWHR:S.Nowicki,DDS(09/05–06/07)

Date: 08/2005–07/2010Funding: NIH(NCRR)G12RR03032;$11,168,682

COMMITTEERESPONSIBILITIES:

A. INTERNATIONAL:

1. ProgramCommittee,12thInternationalPathogenicNeisseriaConference;1999-2000

2. Co-organizerof12thInternationalPathogenicNeisseriaConference;1998-2000

3. ChairSession,8thInternationalCongressonAutoimmunity;Spain,May9-13,2012

4. Chair,InternationalInfectiousDiseaseSocietyforObstetricsandGynecology,USA,May2012

B.NATIONAL:1. NationalStudentsResearchForum;1993-9/2005

C. LOCALATUTMB:1. SearchCommitteeforResearchFacultyofObstetricsandGynecology;1991-9/20052. SearchCommitteeforFellowshipofMaternalFetalMedicine;1996-20053. CommitteeforMcLaughlinFellowshipforExcellenceinImmunology;1997-19994. MedicalSchoolAdmissions(Interviewingcandidates);1993-20055. SearchCommitteeforBacteriologyFacultyinMicrobiology&

ImmunologyDepartment;19996. Judgefor13thAnnualUTMBUndergraduateResearchSymposium;19997. SearchCommitteeforFacultyforPediatrics/SealyCenterforVaccineDevelopment;2000

8. Judge,16thAnnualUndergraduateResearchSymposium(forUnderrepresentedStudents);1995-2005.

9. MemberofExecutiveBoardoftheFacultyWomen’sCaucus;2000-9/2005

C2.LOCALATMEHARRYMEDICALCOLLEGE:

1. ChairSearchCommitteeforCenterforWomen’sHealthResearchfaculty

Position;2006-2007.2. SearchcommitteeforNationalCenterforOptimalHealth–Director

Position;2006-2007.3. SearchcommitteeforNationalCenterforOptimalHealth–faculty

positionEpidemiologistandstatistician;2007.4. SearchcommitteeforCenterforWomen’sHealthResearch–Program

Manager;20065. SearchcommitteeforDepartmentofCardiovascularResearch–Chair

Position;2006-2007.6. InternalAdvisoryCommitteeforRCMI;2005-20087. Director,TissueAcquisitionCoreFacility;20078. MedicalSchoolInterviews;2007-20109. Co-directorMicrobiologyCourseinGraduateSchool2009-present10. DirectorforCollaborationsandPartnerships2010-present

D. DEPARTMENTAL:

1. UTMBOb/GynFellowshipCommittee;1996-20052. UTMBSearchCommitteeforResearchFacultyofOb/Gyn;1995-

9/20053.MMCSearchCommitteeforOB/GynFaculty;2006-20074.MMCMicrobiologyandImmunologygraduatestudentslabrotation;2005-2010 5.MMCOB/GYNResidenceinterviews2006-20106.CommitteeMember,MicrobiologyandImmunologyDepartmentalSeminarProgram,MMC;2009-20107.Chair,DepartmentalSeminarProgramMicrobiologyandImmunologyMMC;2010-2014

E. OTHER:1. Member,KosciuszkoFoundation(PolishLiterature);1995-19972. Judge,GalvestonCountyScienceFairforHighSchoolStudents;1991-

9/20053. JournalofInfectionandImmunity;ADHOCReviewersince;-19974. JournalofClinicalandDiagnosticLaboratoryImmunology;ADHOC

Reviewer;2000-present5. JournalofMolecularMicrobiology;ADHOCReviewer;since–19996. ScientificCommitteeMember,McLaughlinFundforExcellencein

Immunology(GrantsRevision);1997–20057. TheNationalAuthorsRegistry,USA;1998-present8. AmericanPenWoman;2007-present 9. PLoS ONE Journal;ADHOCReviewer;2011-present

TEACHINGRESPONSIBILITIESATUTMBandMMC:

a. MEDICALSCHOOL:1. MedicalMicrobiologyCourse;1994-2005atUTMB2. IntroductiontoPatientEvaluation(IPE);1996-1999atUTMB3. CommunityContinuityExperience(CCE);1996-1999atUTMB4. InteractiveLearningTract(ILT);1996-19995.Ob/GynGrandRounds;1997-20056.MedicalSchoolInterviews;1998-20057.PracticeofMedicinecourseblock;FirstYearMedicalStudents;1999-

2002atUTMB8.IntegratedCurriculumEvaluationExercise(ICEE);1999-20029.SmallGroupFacilitatorGrossAnatomyCourse;200010.SmallGroupFacilitatorCardio-PulmonaryCourse;200011.SmallGroupFacilitatorAnatomyandNeurologyCourse;2001-200212.SmallGroupFacilitatorEndocrinologyCourse;2002-200313.SmallGroupFacilitatorNeuro/HumanBehavior;200214.FacilitationCVPLabCourse/MicroLabPart;2002–200315.SmallGroupFacilitator:Renal,FluidsandElectrolytes;200416.OB/GynGrandRoundsatMMC;2005-201017.Organizing Committee Chair for Meharry Translational Research Center

(MeTRC) Open House March 11, 2011

18.MedicalSchoolInterviewsatMMC;2007-2013 19. Committee Chair for Microbiology and Immunology Departmental

Seminars; 2009-2014 20. Integrated Curriculum Facilitator at MMC; 2011- present 21. Medical Microbiology (PID) Small Group Discussions at MMC;

2013 22. Fundamentals in Microbiology: G+ Bacilli: Corynbacterium diphtheria, Listeria monocytogenes, Bacillus (anthrax and other), Actinomyces ; MMC, 2011-2015 23. MICR 707 PhD students : Gram negative cocci: Neisseria gonorrhoea, Neisseria meningititis, Moraxella ;MMC, 2012-2015 24. Embryology; small group discussion for MD students at MMC 2012- present

b. GRADUATESCHOOL:

1. PathogenicBacteriologyCourseatUTMB;1995-20052. AdvancedImmunologyCourseatUTMB;1998-20013. AppointedaSpecialMemberoftheGraduateFacultyofTheUniversityof

TexasGraduateSchoolofBiomedicalSciences;1998-20054. MedicalMicrobiology,SupplementationforGraduateStudents;1999-20055. RecruiterforUTMBattheGraduate&ProfessionalCareerFairatLoyola

University,NewOrleans,LA;10/20006. Mentorfor4Ph.D.students,UTMB1998-20057. Professor,DepartmentofBiomedicalSciences,DivisionofMicrobial

PathogenesisatMeharryMedicalCollege,Nashville,TN,since9/2005-2007.

8. Mentorfor2Ph.D.StudentsMMC,2007-20089. Mentorfor5PhDstudent/rotationMMC2007-201010. ImmunologyCourseforgraduatestudentsatMMC;2009-present11. Judge: MMC Research Day March 23, 2011 Poster Session 12. Organizing Committee Chair for Meharry Translational Research Center

(MeTRC) Open House March 11 2011 13. PathogenicBacteriologyCourseatMeharryMedicalCollegeSpring

Semester2010-2011

MEMBERSHIPINSCIENTIFICSOCIETIES:

A. INTERNATIONAL1.InternationalInfectiousDiseaseSocietyforObstetricsandGynecology;1993-present

2.KosciuszkoFoundation(PolishLiterature);1995-20023.InternationalPathogenicNeisseriaSociety;1989-2003

B. NATIONAL1. AmericanSocietyforMicrobiology;since19912. AmericanAssociationfortheAdvancementofScience;1993–20023. AssociationofProfessorsofGynecologyandObstetrics;1997-20024. TheNationalAuthorsRegistry(AmericanLiterature);1998-20025. InfectiousDiseaseSocietyforOb/GYN;1998-present

C. LOCALatUTMB

1. TexasSocietyofInfectiousDiseases;1991-20022. FacultyWomen’sCaucus,UTMB;1992-20053. UTMBMultidisciplinaryInfectiousDiseasesGroup;1998-20054. UTMBImmunologySeminarSeries;–1996-20055. President-FacultyWomen'sCaucus;UTMB;1999-20006. PresidentElectFacultyWomen'sCaucus;UTMB1998-19997. ExecutiveBoardoftheFacultyWomen’sCaucus;since2000

HONORS:1. Dean’sScholarship–MedicalStudent;1977-19782. Dean’sScholarship–MedicalStudent;1978-19793. TravelAward–7thInternationalPathogenicNeisseriaConference,Berlin,

Germany;19904. ASMPressAward-PostdoctoralFellow,BaylorCollegeofMedicine;19915. Moderator-Session50-BeacheyMemorial-ASM,LasVegas,NV,May1994.6. VisitingProfessor,Paris,June;19977. 3differenthonorablementions-SolMagazineforPoetry;19998. PosterAwardMcLaughlinFoundation,Co-investigator;19989. PresidentElect-FacultyWomen'sCaucus,UTMB;1998-1999

10. BestPosterAward-“11thInternationalNeisseriaConference,Nice,France;1998

11. BestPosterAward-10thInternationalCongressofImmunology,NewDelhi,India(Co-investigator);1998

12. Co-organizerofthe12thInternationalPathogenicNeisseriaConference(IPNC),1998-2000

13. President-FacultyWomen'sCaucus,UTMB;1999-200014. MemberofOrganizingCommittee-12thInternationalPathogenicNeisseria

Conference;1999-200015. BestPosterAward-SharonMcConley-UndergraduateStudent-Summer

ResearchProgram(MentorforUnderrepresentedStudent);199916. PosterAward–7thEuropeanMeetingonComplementinHumanDisease,

1999,Helsinki,Finland(Co-investigator);199917. ASMPressAward(Mentor);200018. TwoPosterAwards-12thInternationalPathogenicNeisseriaConference

(PrincipleInvestigator);200019. Moderator,GuestLecture-Dr.FeridMurad,MD,PhD,NobelLaureate,12th;

200020. FacultyResearchAward,JohnSealyCenteronAging;2001.21. LifeScienceSymposium,UTMB,Galveston,TX,AbstractAward;5/200222. Co-mentorforGraduateStudentEdytaPawelczykwhoreceivedsix

distinguishedawardsforresearch2003-200423. EndowmentProfessorship,CenterforWomen’sHealthResearch,MMC,

2005-20724. FirstScientificDirector,CenterforWoman’sHealthResearchatMMC,

supportedbyNIH;2005-200725. Director, Collaborations and Partnerships for Meharry Translational Research

Center (MeTRC) at MMC, supported by NIH; 2010-2014 26. S. Nowicki- nominated as a honorable member for The International

Women’s Leadership Association; May 25, 2012 27. S. Nowicki- invited Speaker "New Dimension in Immunotherapy" 3rd Annual

World Congress of Immuno-diseases and Therapy, 10/12, 2013, Dalian 28. S. Nowicki nominated Editorial Board Member to the World Journal of

Clinical Infectious Diseases (WJCID); March 2012 29. Reviewer /RCMI Conference (Scientific Program); 09/2011-12/2012

ADDITIONALINFORMATION:

A. PATENTS:1. NowickiS,NowickiB,AndersonGD.MethodofDifferentiatingPelvic

InflammatoryDiseaseandLocalIsolatesofNeisseriaGonorrhoeae.USSN08/644,426;May13,1996–approved–10/1998

2. NowickiS,NowickiB,MartensM,AndersonGD.ModelsforGonococcalInfection.SN08/045,490;4/8/1993.

3. NowickiS.Alzheimer’sDiseaseVaccine;inpreparation.4. NowickiS.etalDiagnosticTestforPretermLabor;inpreparation.5. NowickiS.etalDiagnosticTestforCardiovascularDiseaseinAAwomen;

inpreparation2012.

B. INVITEDSPEAKER:1. SpeakerandRoundTableDiscussionMember,ThirdWorldInternational

CongressofInfectiousDiseasesinOB/GYN,Acapulco,Mexico;1993.

2. ModeratorandSpeaker-Session50-BeacheyMemorial-DivisionBlectureMolecularMechanismofSexuallyTransmittedDiseases.AmericanSocietyofMicrobiology,LasVegas,NV;5/1994.

3. InvitedSpeaker-ExperimentalGonococcalInfectionCausedbyPelvicInflammatoryDisease(PID)IsolatesisPreventedbyAnti-C1q-antibodies.TexasForumonFemaleReproduction,Houston,TX;5/1995.

4. InvitedSpeaker-NewPerspectivesinDiagnosisofGonococcalPID.NationalInstituteofHealth,Warsaw,Poland;6/1997.

5. InvitedSpeaker–MolecularMechanismInvolvesinPathogenesisofGonococcalInfection.MedicalSchoolGdanskUniversity,Poland;6/1997.

6. InvitedSpeaker-ParadoxicalEffectofHumanComplementC1qonN.Gonorrhoeae;ProtectionversusDamage.TexasASMConference,Houston,TX;11/1997.

7. InvitedSpeaker-ProtectionversusDamageofHumanComplementC1qonN.Gonorrhoeae.UniversityofGdansk,Poland;6/1998.

8. InvitedSpeaker–TheMechanismofGonococcalPelvicInflammatoryDisease.UniversityofNorthCarolina,ChapelHill,NC;8/2000.

9. Moderator,PosterSummaries:HostDefense/ResponsestoNeisserialInfections.12thInternationalPathogenicNeisseriaConference,MoodyGardens,Galveston,TX;11/2000.

10. Moderator,GuestLecture-Dr.FeridMurad,MD,PhD,DirectorandChairmanofBiologyandPharmacologyDepartment.UniversityofTexas,NobelLaureate“CellularSignalingwithNitricOxideandCyclicGMP”,12thInternationalPathogenicNeisseriaConference,MoodyGardens,Galveston,TX;11/2000.

11. Speaker–GonococcalPID,DepartmentofOb/GynGrandRounds,UTMB,Galveston,TX;4/2002.

12. Speaker–PathogenicityIslandinNeisseriaGonorrhoeae.UTMBMicrobiologyImmunologyResearchSeminar.UTMB,Galveston,TX;5/2002.

13. Co-author,Decay-AcceleratingFactor:Structure-Function–FunctionAnalysisofResiduesEffectingInvasionofDrFimbriatedEscherichiaColitoEpithelialCells.AegeanConference,MykonosGreece;2003.

14. Co-author,PretermLabor,InfectionandTLR-Receptor:ProtectionversusRejection.SymposiumGdanskTechnicalUniversity,GdanskPoland;2003.

15. Speaker,GrandRounds,DepartmentofMicrobiologyandImmunology,UniversityofGdansk,Poland;6/2003.

16. Co-author,Toll-LikeReceptor4ExpressioninRatPregnancyanditsRegulationInfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG);2003.

17. Speaker,GenderSpecificRiskFactorForComplicatedGonococcalInfectionsInfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG);2003.

18. InvitedSpeaker,Decay-AcceleratingFactor:Structure-Function–FunctionAnalysisofResiduesEffectingInvasionofDrFimbriatedEscherichiaColitoEpithelialCells.AegeanConference,MykonosGreece;2003.

19. InvitedSpeaker,PretermLabor,InfectionandTLR-Receptor:ProtectionversusRejection.SymposiumGdanskTechnicalUniversity,GdanskPoland,2003.

20. Co-I,EstrogenIncreasesMenopausalHostSusceptibilitytoExperimentalAscendingUrinaryTractInfection.NowickiB,CurranE,EstesM,HartA,MontgomeryRiceV,NowickiS.SocietyforGynecologicInvestigationAnnualScientificMeeting,03/22/2006-03/25/2006(Toronto,ON,Canada).

21. Co-I,TypeIaGroupBStreptococcusExploitsPI3K/AktSignalingPathwaytoInvadeHumanEndometrialCells.GoluszkoP,JonesA,PopovV,NowickiS,NowickiB,YallampalliC.SocietyforGynecologicInvestigationAnnualScientificMeeting,03/22/2006-03/25/2006(Toronto,ON,Canada).

22. PI,RacialDisparitiesinPretermLaborRoleofTLR-4.NowickiS,HartA,PawelczykE,MontogmeryRiceV,andNowickiB.NationalLeadershipSummitonEliminatingRacialandEthnicDisparitiesinHealth,01/09/2006(Washington,DC).

23. PI,PretermLaborinAfricanAmericanWomenisAssociatedwithLowLevelofCD55.NowickiS,PachecoL,HartA,PawelczykE,MontgomeryRiceV,andNowickiB.SocietyforGynecologicInvestigationAnnualScientificMeeting,03/22/2006-03/25/2006(Toronto,ON,Canada).

24. PI,PretermLaborinAfricanAmericanWomenisAssociatedwithLowLevelofCD55.NowickiS,PachecoL,HartA,PawelczykE,MontgomeryRiceV,LadsonG,WhittyJ,andNowickiB.MeharryMedicalCollegeDepartmentofObstetricsandGynecology3rdAnnualResearchSymposium,04/06/2006,(Nashville,TN).

25. PI,DoesComplementMatterintheFemaleReproductiveTract?NowickiS.26thAnnualMeetingoftheAmericanSocietyforReproductiveImmunology,06/15/2006–06/17/2006(Nashville,TN).

26. PI,MaternalImmuneDefenseinRacialDisparitiesofPretermLabor.NowickiS,PawelczykE,WhittyJ,Montgomery-RiceV,LadsonG,Hart-VanTasseA,andNowickiB.TheInfectiousDiseasesSocietyforObstetricsandGynecology33rdAnnualScientificMeetingandSymposium,08/02/2006-08/05/2006(Monterey,CA).

27. PI,CanExpressionofComplementInhibitorCD55PredictPretermLaborinAfricanAmericanWomen?NowickiS,WhittyJ,PachecoL,AudreyHart-

VanTasseA,PawelczykE,MontgomeryRiceV,andNowickiB.“WhyOurBabiesDie”Conference09/19/2006(Nashville,TN).

28. PI,InfectionandImmunityofCardiovascularDisease.NowickiS,3rdJamesSymposium,04/2007(Nashville,TN)

29. InvitedSpeaker;PossibleMechanismofPTDinAfricanAmericanWomen.NowickiS,PachecoL,MontgomeryRiceV,PawelczykEandNowickiB.NationalMedicalAssociation.08/04/2007-08/09/2007(Honolulu,HI).

30. PretermLabor:NovelMolecularMethodsforDiagnosis.Nowicki

S.SymposiumInfectiousComplicationsinHospitalEnvironment;

SocietyforClinicalMicrobiology;GdanskMedicalUniversityPolandNovember/2009

31. Gestationalpyelonephritis:Fromurinaryobstructiontovirulenceandimmuneadaptation.NowickiBandNowickiS.SymposiumInfectiousComplicationsinHospitalEnvironment:SocietyforMicrobiology.GdanskMedicalUniversity,PolandNovember/2009

C. EDITORIALRESPONSIBILITIES/INVITEDREVIEWER:

1. NIHReviewer,Newly-FormedNIH/CSRStudySection.IRAP(InfectiousDiseases,ReproductiveHealth,AsthmaandPulmonaryConditionsStudySection)Thesectionreviewsepidemiologyapplicationsintheareasofinfectiousdiseases,reproductivehealth,asthma,andnon-malignantpulmonaryconditions;2006/2007andJuly2009

2. NIHReviewer,NIHOral,DentalandCraniofacialSciencesStudySection(ODCS);6/20/2006–6/21/2006

3. InvitedInternalReviewerfortheMBRSSCOREInternalAdvisoryCommittee(IAC),MeharryMedicalCollege;6/2006.

4. InvitedtoTheReviewBoardoftheAmericanJournalofHealthBehavior.May/June,2006.

5. Ad-hocreviewer/InfectionandImmunityJournal;2002-present

6. Ad-hocreviewer/Bio-MedCentralJournal/Pregnancy;2009-present 7. Judge: Reproductive Immunology PosterSession SGI Conference, Miami,

FL, March 7, 2011. 8. Editorial Board of World Journal of Clinical Infectious Diseases

(WJCID) 2011-2015

9. Ad-hoc reviewer/PLoS ONE; 2011-present

10. C. NATIONALRECOGNITION:

1. HuongL(Editor-Author).GeneforVirulentNeisseriaGonorrhoeaeStrainIdentifiedasPotentialPIDMarker.ClinicalLabLetterJuly2002;1(13)97-100.

2. ReviewbyEditor.PelvicInfectionTiedToBacterialGene.ScienceNews,Vol157,Jun2000.

3. PI,RacialDisparitiesinPretermLabor-RoleofTLR-4.NowickiS,HartA,

PawelczykE,MontogmeryRiceV,andNowickiB.NationalLeadershipSummitonEliminatingRacialandEthnicDisparitiesinHealth,01/09/2006(Washington,DC).

CommunityService:

1. ChairSearchCommitteeforCenterforWomen’sHealthResearchfacultyPosition;2006-2007.

2. SearchcommitteeforNationalCenterforOptimalHealth–DirectorPosition;2006-2007.

3. SearchcommitteeforNationalCenterforOptimalHealth–facultypositionepidemiologistandstatistician;2007.

4. SearchcommitteeforCenterforWomen’sHealthResearch–ProgramManager;2006.

5. SearchcommitteeforDepartmentofCardiovascularResearch–ChairPosition;2006-2007.

6. InternalAdvisoryCommitteeforRCMI;2005-20077. DirectorofTissueAcquisitionCoreFacility;2007

8. MedicalSchoolInterviews;2007-20089. CWHRCommunityBoardMemberandRetreatParticipant2005-200810. PresentationforUndergraduateSummerSchoolProgram2006-200711. CWHRBenefitConcertParticipant2006-200712. LeadersForum:CommitteeforResearchEnterprise2006-200713. ScienceFairJudge1996-200514. TexasChapterofKosciuszkoFoundation,MemberatLarge,1995-199715. PresidentofWoman’sFacultyAssociation16. ParticipantinNationalLeadershipSummitonEliminatingRacialandEthnic

DisparitiesinHealth,WashingtonD.C.200617. ParticipantinJamesResearchSymposium,MMC.2006-200918. EndometriosisSymposium,Vanderbilt200719. SpeakeratNashville’s“WhyOurBabiesDie”Conference.September200820. PreventionofCardiovascularDiseaseinWoman,CommunityPresentation,

MMC200721. NewdiagnostictestforPTL–patentinpreparation201022. ServedontheCWHRMembershipRecruitmentCommittee200723. MemberofVanderbilt/MeharryMicrobiologyCore,200724. DonatingMemberofMMCCircleofFriends2006-201225. AnnualdonationstoSalvationArmy,andGoodwill1997-2011

PUBLICATIONS:

A. ARTICLESINPEER-REVIEWEDJOURNALS:

1. NowickiB,HartA,CoyneKE,LublinDM,NowickiS.ShortConsensusRepeat-3DomainofRecombinantDecay-AcceleratingFactorisRecognizedbyEscherichiaColiRecombinantDrAdhesininAModelofACell-CellInteraction.JExperMed.(Dec)1993;178:2115-2121.

2. KaulA,NowickiBJ,MartensMG,GoluszkoP,HartA,NagamaniM,KumarD,PhamT,NowickiS.Decay-AcceleratingFactorisExpressedintheHumanEndometriumandMayServeastheAttachmentLigandforDrPiliofEscherichiaColi.AmJReprodImmunol.1994;32:194-199.

3. NowickiB,MartensM,HartA,NowickiS.GestationalAge-DependentDistributionofEscherichiacoliFimbriaeinPregnantPatientswithPyelonephritis.AnnalsoftheNYAcadofSci.(Aug)1994;730:290-291.

4. NowickiS,NowickiB,MartensM,KaulA,FloresG,KumarD.HostFactorsintheAttachmentofGonococcalCellstothePelvicTissue.AnnalsoftheNYAcadofSci.(Aug)1994;730:292-294.

5. PhamT,KaulA,HartA,GoluszkoP,MouldsJ,NowickiS,LublinD,NowickiBJ.Dra-RelatedXAdhesinsofGestationalPyelonephritis-AssociatedEscherichiaColiRecognizeSCR-3andSCR-4DomainsofRecombinantDecay-AcceleratingFactor.InfectImmun.(May)1995;63(5):1663–1668.

6. GoluszkoP,NowickiS,KaulA,PhamT,NowickiBJ.DrFimbriaeCodingRegionAssociatedHemolyticActivityofEscherichiaColi.FEMSMicrobiolLett.(July)1995;130:13-17.

7. GoluszkoP,NowickiB,GoluszkoE,NowickiS,KaulA,PhamT.AssociationofColonyVariationinSerratiaMarcescenswiththeDifferentialExpressionofProteaseandType1Fimbriae.FEMSMicrobiolLett.(Oct)1995;133:41-45.

8. NowickiS,NowickiB,MartensM.GonococcalInfectioninNonhumanHostisDeterminedbyHumanRecombinantC1q.InfectImmun.(Dec)1995;63(12):4790-4794.

9. KaulA,GoluszkoP,HartA,MartensM,PhamT,NowickiS,NowickiB.RapidCyclicChangesinDensityandAccessibilityofEndometrialLigandsforEscherichiaColiDrFimbriae.InfectImmun.(Feb)1996;64:611-615.

10. HartA,PhamT,NowickiS,WhortonEDJr.,MartensMG,AndersonGD,NowickiBJ.GestationalPyelonephritis-AssociatedEscherichiaColiIsolatesRepresentaNonrandom,CloselyRelatedPopulation.AmJObstetGynecol(Mar)1996;174:983-989.

11. MouldsJM,NowickiS,NowickiB,MouldsJJ.HumanBloodGroups:IncidenceReceptorsforVirusesandBacteria,Transfusion(April)1996;36:362-374.Invitedreview.

12. GoluszkoP,MoseleyS,TruongL,KaulA,WillifordJ,SelvaranganR,NowickiS,NowickiB.DevelopmentofExperimentalModelofChronicPyelonephritiswithEscherichiaColi075:K5:H-BearingDrFimbriae:MutationintheDraRegionPreventedTubulointerstitialNephritis.JClinInvest(April)1997;99(7):1662-1672.

13. NowickiS,RamP,PhamT,GoluszkoP,MorseS,AndersonGD,NowickiB.PelvicInflammatoryDiseaseIsolatesofNeisseriagonorrhoeaeareDistinguishedbyC1q-dependentVirulenceforNewbornRatsandbythesac-4Region.InfectImmun(June)1997;65:(6):2094-2099.

14. GoluszkoP,PopovV,SelvaranganR,NowickiS,PhamT,NowickiB.DrFimbriaeOperonofUropathogenicEscherichiaColiMediateMicrotubule-DependentInvasiontotheHelaEpithelialCellLine.JInfectDis(July)1997;176:158-67.

15. NowickiB,FangL,SinghalJ,NowickiS,YallampalliC.LethalOutcomeofUterineInfectioninPregnantButNotinNonpregnantRatsandIncreasedDeathRatewithInhibitionofNitricOxide.AmJReprodImmun(Oct)1997;38:309-312.

16. PhamTQ,GoluszkoP,PopovV,NowickiS,NowickiBJ.MolecularCloningandCharacterizationofDR-II,aNon-FimbrialAdhesin-I-LikeAdhesinIsolatedfromGestationalPyelonephritis-AssociatedEscherichiaColithatBindstoDecay-AcceleratingFactor.InfectImmun(Oct)1997;65(10):4309-4318.

17. GoluszkoP,MoseleySL,TruongLD,KaulA,WillifordJR,SelvaranganR,NowickiS,NowickiBJ.DevelopmentofExperimentalModelofChronicPyelonephritiswithEscherichiacoliO75:K5:H-BearingDrFimbriae:MutationintheDraRegionPreventedTubulointerstitialNephritis.JClinInvest(Apr)1997;99(7):1662-1672.

18. NowickiBJ,SinghalJ,FangL,NowickiS,YallampalliC.InverseRelationshipBetweenSeverityofExperimentalPyelonephritisandNitricOxideProductioninC3H/HejMice.InfectImmun1999;67(5):2421-2427.

19. NowickiS,SelvaranganR,AndersonG.ExperimentalTransmissionofNeisseriaGonorrhoeaefromPregnantRattoFetus.InfectImmun1999;67(9):4974-4976.

20. SelvaranganR,GoluszkoP,PopovV,SinghalJ,PhamT,LublinDM,NowickiS,andNowickiB.RoleofDecay-AcceleratingFactorDomainsandAnchorageinInternalizationofDrFimbriatedEscherichiacoli.InfectImmun(Mar)2000;68(3).

21. NowickiS,HartA,NowickiB.SusceptibilitytoGonococcalInfectionDuringtheMenstrualCycleJAMA(Mar)2000;283(10):1291-1292.

22. GoluszkoP,SelvaranganR,NowickiBJ,NowickiS,HartA,PawelczykE,NguyenK.RapidReceptor-ClusteringAssaytoDetectUropathogenicandDiarrhealEscherichiacoliBearingAdhesinsofDrFamily.JClinMicro(Jun)2001;39(6):2317-20.

23. HartA,NowickiBJ,ReisnerB,PawelczykE,GoluszkoP,UrvilP,AndersonG,andNowickiS.Ampicillin-resistantEscherichiacoliinGestationalPyelonephritis:IncreasedOccurrenceandAssociationwiththeColonizationFactorDradhesin.JInfectDis(May)2001;183(10):1526-9.

24. NowickiB,SelvaranganR,NowickiS.FamilyofEscherichiacoliDrAdhesins:Decay-acceleratingFactorReceptorRecognitionandInvasiveness.JInfectDis(Mar)2001;183(Suppl1):S24-7.

25. GoluszkoP,NieselD,NowickiB,SelvaranganR,NowickiS,HartA,PawelczykE,DasMUrvilPandHasanR.DrOperon-associatedInvasivenessofEscherichiacolifromPregnantPatientswithPyelonephritis.InfectImmun(Jul)2001;69(7):4678-4680.

26. NowickiS,NowickiB,PhamT,HasanR,NagamaniM.ExpressionofDecayAcceleratingFactor(DAF)inEndometrialAdenocarcinomaisInversely

RelatedtotheStageofTumor.AmJReprodImmunol(Aug)2001;46:144-48.

27. HasanRJ,PawelczykE,UrvilP,VenkatarajanMS,GoluszkoP,KurJ,SelvaranganR,NowickiS,BraunWA,NowickiBJ.Structure-FunctionAnalysisofDecayAcceleratingFactor.IdentificationofResiduesImportantforBindingofEscherichiacoliDr-adhesinandComplementRegulation.InfectImmun(Aug)2002;70(8):4485-4493.

28. ZalewskaB,PiatekR,KonopaG,NowickiB.,Nowicki,S.,Kur,J.ChimericDr.FimbriaewithaHerpesSimplexVirusType1EpitopeasaModelforaRecombinantVaccine.Infect.Immun.(Oct)2003;71:5505-5513

29. Fang,L.,Nowicki,B.J.,Urvil,P.,Goluszko,P.,Nowicki,S.Young,S.L.andYallampalli,C.EpithelialInvasionbyEscherichiacoliBearingDrFimbriaeisControlledbyNitricOxide-RegulatedExpressionofCD55.InfectImmun(May)2004;72:2907-2914

30. SelvaranganR,GoluszkoP,SinghalJ,CarnoyC,MoseleyS,HudsonB,NowickiS,NowickiBJ.InteractionofDr-AdhesinwithCollagenType-IVisaCriticalStepinEscherichiaColiRenalPersistence.InfectImmun(Aug)2004;72:4827-4835

31. GoluszkoP,GoluszkoE,NowickiB,NowickiS,PopovV,WangHQ.VaccinationwithPurifiedDrFimbriaeReducesMortalityAssociatedwithChronicUrinaryTractInfectionDuetoEscherichiacoliBearingDrAdhesin.InfectImmun.(Jan)2005;73(1):627-31.

32. ZalewskaB,PiatekR,BuryK,SametA,NowickiB,NowickiS,KurJ.ASurface-ExposedDradProteinofUropathogenicEscherichiacoliBearingDrFimbriaeMaybeExpressedandSecretedIndependentlyfromDracUsherandDraeAdhesin.Microbiology(Jul)2005;151(Pt7):2477-86.

33. DasM,Hart-VanTassellA,UrvilPT,LeaS,PettigrewD,AndersonKL,SametA,KurJ,MatthewsS,NowickiS,PopovV,GoluszkoP,NowickiBJ.HydrophilicDomainIIofEscherichiacoliDrFimbriaeFacilitatesCellInvasion.InfectImmun(Sep)2005;73(9):6119-26.

34. Wroblewska-SeniukK,SelvaranganR,HartA,PladzykR,GoluszkoP,Jafari

A,duMerleL,NowickiS,YallampalliC,LeBouguenecC,NowickiB.Dra/AfaEAdhesinofUropathogenicDr/Afa+EscherichiacoliMediatesMortalityinPregnantRats.InfectImmun(Nov)2005;73(11):7597-601.

35. RiceJC,PengT,SpenceJS,WangHQ,GoldblumRM,CorthesyB,NowickiBJ,NowickiS.PyelonephriticEscherichiacoliExpressingPFimbriaeDecreaseImmuneResponseoftheMouseKidney.JAmSocNephrol(Dec)2005;16(12):3583-91.

36. RiceJC,PengT,KuoYF,PendyalaS,SimmonsL,BoughtonJ,IshiharaK,NowickiS,NowickiBJ.RenalAllograftInjuryIsAssociatedwithUrinaryTractInfectionCausedbyEscherichiacoliBearingAdherenceFactors.AmJTransplant.(Oct)2006;6(10):2375-83

37. CurranE,Hart-VanTassellA,JudyBM,NowickiB,Montgomery-RiceV,EstesDM,NowickiS.EstrogenIncreasesMenopausalHostSusceptibilitytoExperimentalAscendingUrinaryTractInfection.Infection.JInfectDis.(Mar)2007;195(5):680-3.

38. NowickiS,IzbanMG,PawelczykE,AgbotoV,PratapS,OlsonG,Nowicki

BJ.PretermLabor:CD55inMaternalBloodLeukocytes.AmJRepImmun.61(5):360-7; 2009.

39. Nowicki, B., Sledzinska, A., Samet, A. and Nowicki, S. 2010. Pathogenesis of gestational UTI: urinary obstruction vs. immune adaptation and microbial virulence. British Journal of Gynecology.2011 January;118;2:109-112

40. Pawelczyk, E., Nowicki, B.J., Izban, M.G., Pratap, S., Sashti, N.A., and Nowicki, S. 2010. Spontaneous preterm labor is associated with an increase in the proinflammatory signal transducer TLR4 receptor on maternal blood monocytes. BMC /Pregnancy Childbirth. 2010 October 21;10:66

41. Sledzinska, A., Mielech, A., Krawczyk, B., Samet, A., Nowicki, B.J., Nowicki, S., Jankowski, Z., and Kur, J. 2010. Fatal sepsis in a 23-year-old pregnant woman with pyelonephritis caused by Escherichia coli bearing Dr and P adhesins: diagnostic value of postmortem genotyping of isolated strains. British Journal of Obstetrics and Gynecology. 2010; 118, 2, 266–269, 2011

42. Pacheco LD, Hankins GD, Costantine MM, Anderson GD, Pawelczyk E, Nowicki S, Nowicki BJ. 2011. The Role of Human Decay-Accelerating Factor in the Pathogenesis of Preterm Labor. Am J Perinatol. 2011 March 4 in press

43. Wroblewska-Seniuk K., Nowicki S., Le Bouguénec C , Nowicki B. , Yallampalli C. Maternal/fetal mortality and fetal growth restriction: Role of nitric oxide and virulence factors in intrauterine infection in rats, Am. J. Obstet. Gynecol. 2011 March in press.

44. Nowicki B, A Sledzinska, A Samet, S. Nowicki. Pathogenesis of gestational UTI: urinary obstruction vs. immune adaptation and microbial virulence. BJOG 2011 Jan; 118 (2):109-12 Editorial.

45. Michael G. Izban, Bogdan J. Nowicki and Stella Nowicki. 1,25-Dihydroxyvitamin D3 Promotes a Sustained LPS-induced NF-κB-dependent Expression of CD55 in Human Monocytic THP-1 cells. PLoS ONE. 2012; 7(11): 49318.doi:10.1371/journal.pone.0049318

46. Nowicki B, Nowicki S. DAF as a Therapeutic Target for Steroid Hormones: Implication for Host-Pathogen Interactions. Adv Exp Med Biol. 2013; 734:83-96

47. Siddharth Pratap, Laura E. Brown, Michael G. Izban, Stella Nowicki, and

Bogdan J. Nowicki Accurate Preterm Labor Diagnosis Using a CD55 - TLR4 Combination Biomarker Model J. Biomed Sci & Engineering, Accepted for publication (March 2013)

48. Samet F, Sledzinska M, Nowicki S, Kur J, Nowicki B; Leukemia and risk of

recurrent E. coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream. European Journal of Clinical Microbiology & Infectious Diseases No. EJCMID-D-13-00112 (In press May 2013)

49. Samet F, Krawczyk B, Nowicki B, Sledzinska M, Nowicki S, Kur J; A Subset of

Two Adherence Systems, Acute Pro-Inflammatory pap Genes and Invasion Coding dra, fim or sfa, Increase the Risk of Escherichia coli Translocation to the Bloodstream European Journal of Clinical Microbiology & Infectious Diseases No. EJCMID-D-13-00336R1 (Accepted for publication Jun 2013)

50. Putonti C, Nowicki B, Shaffer M, Fofanov Y, Nowicki S. Where does Neisseria acquire

foreign DNA from: an examination of the source of genomic and pathogenic islands and the evolution of the Neisseria genus. BMC Evol Biol. 2013 Sep 4; 13(1):184

51. Rana T, Hasan RJ, Nowicki S, Venkatarajan MS, Singh R, Urvil PT, Popov V, Braun

WA, Popik W, Goodwin JS, Nowicki BJ. Complement Protective Epitopes and CD55-Microtubule Complexes Facilitate the Invasion and Intracellular Persistence of Uropathogenic Escherichia coli. J Infect Dis. 2014 Apr;209(7):1066-76. PMID: 24259524

52. Banadakoppa M1, Goluszko P, Liebenthal D, Nowicki BJ, Nowicki S, Yallampalli C. PI3K/Akt pathway restricts epithelial adhesion of Dr+ Escherichia coli by down-

regulating the expression of decay accelerating factor. Exp Biol Med (Maywood). 2014 May;239(5):581-94

53. Ansley AJ, Rana T, Nowicki S, Nowicki B. Progesterone Receptors Signaling and Upregulation of Decay-Accelerating Factor (DAF/CD55). Obstet. Gynecol. 2014

May;123 Suppl 1:135S-6S

54. Rana T, Udoko AN, Johnson CA, Singh R, Rachakonda G, Lima MF, Villalta F, Mandape SN, Lawler J, Pratap S, Nowicki S, Nowicki B, and Nde PN.

THROMBOSPONDIN-1 IN HOST PATHOGEN INTERACTIONS; Circulation. 2014 June

B. ARTICLESINBOOKS:

1. NowickiS.PossibleMechanismsofSerumResistanceofNeisseriaGonorrhoeaefromDisseminatingInfections.In:AchtmanM,KohnP,MarchalC,MorelliG,SeilerA,ThiesenB.Neisseria1990.NewYork:WalterdeGrutyer;1991:621-6.

2. NowickiS,MartensMG.HostResponsetoFungalInfection.In:ClinicalAdvancesintheTreatmentofFungalInfection.NewYork:KSFPublication;1991:1-12.

3. NowickiS,MartensM,KaulA,NowickiB.GonococcalAttachmenttoHumanOvarianTissue.In:BroomeC,KnappJ,MorseS,RiceP,delRioC,KohlP,NormarkS,SparlingF,eds.PathobiologyandImmunobiologyofNeisseria.Mexico:NationalInstituteofPublicHealth,1993,730-734.

4. NowickiS,LocksmithG,NowickiB.AntiphospholipidAntibodySyndromeandPregnancy.Medicine,Ob/Gyn,Psychiatry,andSurgeryinwww.emedicine.com,2001.

5. NowickiS,GoldblumR,AmnioticFluidandtheFetalMucosalImmuneSystem.In:MestechyJ,BienenstockJ,LammM,MayerL,McGheeJ,StroberW,eds.MuscosalImmunology.3rded.SanDiego,CA:ElsivierInc;2004:Chapter99.

6. NowickiS,LocksmithG,NowickiB.AntiphospholipidAntibodySyndrome

andPregnancy.Medicine,Ob/Gyn,Psychiatry,andSurgeryinwww.emedicine.com,2005.

7. NowickiS,GoldblumR,AmnioticFluidandtheFetalMucosalImmune

System.In:MestechyJ,BienenstockJ,LammM,MayerL,McGheeJ,StroberW,eds.MuscosalImmunology.4rded.SanDiego,CA:ElsivierInc;2013:Chapter112inpreparation

C. MANUSCRIPTSINPROGRESS(3):

D. PUBLISHEDABSTRACTS:

1. NowickiS,HullR,RossenRD.PossibleMechanismsofSerumResistanceofN.GonorrhoeaefromDisseminatedInfections.SeventhInternationalPathogenicNeisseriaConference,WestBerlin;9/1990.

2. NowickiS,MaderJT.BactericidalActivityofAerobicandAnaerobic

LeukocytesAgainstBacteroidesFragilis.UnderseaandHyperbaricMedicalSocietyAnnualScientificMeeting,Anaheim,CA;1991.

3. NowickiS,MartensM,NowickiB.BindingofC1qtoOuterMembrane

ProteinsofNeisseriaGonorrhoeaeandPotentialRoleinPathogenicity(OralPresentation).31stICAACConference,Chicago,IL;10/1991.

4. NowickiB,MartensM,HartA,TaylorB,NowickiS.HostFactors

AffectingTissueAdherencebyPathogenicEscherichiacoliinPregnancy(OralPresentation).31stICAACMeeting,Chicago,IL;1991.

5. RossenRD,SchulmeierGA,NowickiS,HallB,MichaelLH,EntmanML,

BaughnRE.IdentificationofC1qBindingMoleculesinCardiacMitochondriathatContainCardiolipin(OralPresentation).FASEB;1991.

6. Conde-GlezCJ,NowickiS,HullRA.FrequencyofaGeneSequence

EncodingSerumGonococcalResistanceAmongClinicalandReferenceStrainsoftheNeisseria.DepartmentofMicrobiologyandImmunology,BaylorCollegeofMedicine,SocietyofMicrobiology,Houston,TX;1991.

7. NowickiB,MartensM,HartA,TaylorB,NowickiS.FactorsAffecting

TissueAdherencebyPathogenicEscherichiacoliInPregnancy(OralPresentation).MeetingoftheInfectiousDiseaseSocietyforObstetrics-Gynecology;1991.

8. NowickiB,HartA,LublinD,NowickiS.MolecularCharacterizationof

BindingEpitopesonDecayAcceleratingFactor(DAF)forEscherichiacoliClonesthatExpressDr,AFA1,AFA111,andF1845Adhesins.AmericanSocietyofMicrobiologyGeneralMeeting,NewOrleans,LA;5/1992.

9. NowickiB,HartA,NowickiS.MolecularMechanismofInteraction

BetweenEscherichiacoliandHumanChorionicGonadotropinHormone(HCG).AmericanSocietyofMicrobiologyGeneralMeeting,NewOrleans,LA;5/1992.

10. NowickiB,MartensM,HartA,NowickiS.Pyelonephritis-Associated

Gram-NegativeSpeciesinPregnantWomenofDifferentGestationalAge(OralPresentation).FirstInternationalCongressforInfectiousDiseasesinObstetricsandGynecology,Taormina-GiardiniNaxos,Italy;6/1992.

11. NowickiB,MartensM,HartA,MouldsJ,NowickiS.EscherichiaColi

VirulenceandHostFactorsAffectingDevelopmentofPyelonephritisinPregnantWomen(OralPresentation).AnnualMeeting,InfectiousDiseaseSocietyforObstetrics-Gynecology;8/1992.

12. NowickiB,PhamT,MartensM,HartA,NowickiS.Molecular

CharacterizationofHumanChorionicGonadotropinHormone-LikePeptidesofEscherichiacoli(OralPresentation).AnnualMeeting,InfectiousDiseaseSocietyforObstetrics-Gynecology;8/1992.

13. NowickiB,KaulA,NagamaniM,MartensM,KumarD,GoluszkoP,NowickiS.DynamicChangeinTheExpressionofDrReceptorsforEscherichiacoliFimbriaeDuringProliferativeandSecretoryPhaseinHumanEndometrium.SocietyforGynecologicInvestigation;10/2/1992.

14. NowickiS,MartensM.GonococcalAttachmenttoHumanLeukocytesis

EnhancedbyComplementC1q(OralPresentation).1992AmericanSocietyofMicrobiologyGeneralMeeting,NewOrleans,LA;5/1992.

15. NowickiS,NowickiB,MartensM.GonococcalAttachmenttoHuman

OvarianTissue.EighthInternationalPathogenicNeisseriaConference,Cuernavaca,Mor.,Mexico;10/1992.

16. NowickiB,GoluszkoP,MartensM,NowickiS,AndersonGD.Anemia

andHemolyticActivityofEscherichiacoliinPregnantPatientswithPyelonephritis(PosterPresentation).SocietyofPerinatalObstetricians,SanFrancisco,CA;2/1993.

17. NowickiB,KaulA,NagamaniM,MartensM,KumarD,GoluszkoP,

NowickiS.DynamicChangeintheExpressionofDrReceptorsforEscherichiacoliFimbriaeDuringProliferativeandSecretoryPhaseinHumanEndometrium(Poster,OralPresentationas“HotTopic”).40thAnnualMeetingofSGI,Toronto,Canada;3/1993.

18. KaulA,MartensM,NagamaniM,KumarD,LublinD,NowickiS,Nowicki

B.DecayAcceleratingFactor(DAF)istheNaturalReceptorfortheDr-FimbriaeofUropathogenicEscherichiacoliintheHumanEndometrium.AnnualMeetingoftheAmericanSocietyforMicrobiology;Atlanta,GA;5/1993.

19. NowickiB,MartensM,NieselD,DoanR,HartA,KaulA,GoluszkoP,

PhamT,NowickiS.VirulenceFactorsandTissueReceptorsInvolvedintheDevelopmentofEscherichiaColiPyelonephritisintheThirdTrimester(OralPresentation).InfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG)AnnualMeeting;Stowe,VT;8/1993.

20. NowickiB,HartA,MartensM,NowickiS.ParadoxicalIncreaseofResistanceofEnterobacteriaceaetoß-LactamsinPatientswithPyelonephritisDuringtheFirstTrimesterofPregnancy(AcceptedButNotPresented;Poster).InfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG)AnnualMeeting;Stowe,VT;8/1993.

21. NowickiS,NowickiB,MartensM.SpeciesDependentAttachmentof

NeisseriaGonorrhoeaetotheUterus(OralPresentation).InfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG)AnnualMeeting;Stowe,VT;8/1993.

22. NowickiS,NowickiB,MartensMG,AndersonGD.ExperimentalAnimal

ModelforGonococcalInfectionandVaccine(PosterPresentation).BioInternational'93ConferenceandExhibition;Houston,TX;8/1993.

23. NowickiS,NowickiB,MartensMG.HostFactorsinAttachmentof

GonococcalCellstothePelvicTissue(PosterPresentation).MicrobialPathogenesisandImmuneResponseConference;Orlando,FL;9/1993.

24. NowickiB,MartensM,HartA,MouldsJ,NowickiS.GestationalAge

DependentDistributionofEscherichiacoliFimbriaeinPregnantPatientswithPyelonephritis(PosterPresentation).NewYorkAcademyofSciencesMicrobialPathogenesisandImmuneResponseConference,Orlando,FL;9/1993.

25. MartensMG,NowickiS,NowickiB.PossibleVirulenceFactorofN.

GonorrhoeaeAssociatedwithDevelopmentofPelvicInflammatoryDiseases(PosterPresentation).DistrictVIIAnnualMeetingofACOG;ViennaandVenice;10/1993.

26. MartensM,KaulAK,NowickiS,GoluszkoP.PresenceofReceptorsfor

Dr-HemagglutininofUropathogenicE.coliintheUterusofPregnantRats(PosterPresentation).ThirdWorldCongressforInfectiousDiseasesinOb/Gyn;Acapulco,Mexico;10/1993.

27. NowickiS,NowickiB,MartensMG.ComplementC1qontheSurfaceof

GonococcalCellsfromPelvicInflammatoryDisease(OralPresentation).

ThirdWorldCongressforInfectiousDiseasesinOB/Gyn;Acapulco,Mexico;10/1993.

28. KaulA,MartensMG,NowickiS,NowickiB.ExpressionofDecay

AcceleratingFactor(DAF)-LigandforDr-FimbriaeofUropathogenicEscherichiacoliinRatKidneyDuringPregnancy(OralPresentation).11thAnnualTexasImmunologyConference;Galveston,TX;11/1993.

29. KaulA,MartensM,NowickiS,KumarD,NagamaniM,GoluszkoP,Pham

T,HartA,NowickiB.MenstrualCycleAssociatedExpressionofDecayAcceleratingFactor-ReceptorforDr-FimbriaeofEscherichiacoli.AnnualMcLaughlinFellowshipColloquium,Abstract;1993.

30. NowickiB,MartensM,HartA,MouldsJ,NowickiS.GestationalAge

DependentDistributionofEscherichiacoliFimbriaeinPregnantPatientswithPyelonephritis(AcceptedButNotPresented;PosterandOralPresentationas“HotTopic”).AnnualMeeting,AmericanUrologicalAssociation,Inc.,SanAntonio,TX;1993.

31. KaulA,HartA,PhamT,GoluszkoP,MartensM,NowickiS,LublinD,

NowickiB.X-AdhesinsofUropathogenicEscherichiacoliBindtotheSCR-4oftheDecayAcceleratingFactor(DAF),EpitopesProximaltotheCellMembrane(PosterPresentation).KeystoneSymposiaonMolecularandCellularBiology;SantaFe,NM;1/1994.

32. GoluszkoP,NowickiB,KaulA,MartensMG,GarfieldRE,YallampalliC,

NowickiS,AndersonGD.StimulationofPretermLaborbyLipopolysaccharide(LPS)isDependentonGestationalAge(PosterPresentation).SocietyofPerinatalObstetriciansAnnualMeeting,LasVegas,NV;1/1994.

33. NowickiB,HartA,MartensMG,PhamT,NowickiS,AndersonGD.

PlasmidProfilesofEscherichiacoliIsolatesfromPregnantPatientswithPyelonephritisDuringDifferentGestationalAges(PosterPresentation).SocietyofPerinatalObstetriciansAnnualMeeting,LasVegas,NV;1/1994.

34. KaulA,NowickiB,GoluszkoP,MartensMG,NowickiS,AndersonGD.ExpressionofReceptorsfor'P'FimbriaeofE.coliintheRatKidneyDuringPregnancy(PosterPresentation).SocietyofPerinatalObstetriciansAnnualMeeting,LasVegas,NV;1/1994.

35. KaulAK,NagamaniM,MartensMG,GoluszkoP,NowickiS,NowickiBJ.

RoleofProgesteroneintheExpressionofDecayAcceleratingFactor(DAF)TissueLigandforDr-FimbriaeofEscherichiacoli(AcceptedPosterPresentation).SocietyofGynecologicInvestigation;Chicago,IL;3/1994.

36. GoluszkoP,MartensM,NowickiS,NowickiB.HemolyticActivityof

LaboratoryEscherichiacoliStrainEC901CarryingtheDrFimbriaeCodingRegion(Accepted,PosterPresentation).94thAnnualMeetingoftheAmericanSocietyforMicrobiology,LasVegas,NV;5/1994.

37. KaulA,HartA,MartensM,NowickiS,NowickiB.PregnancyAssociated

ExpressionofTissueLigandsforDr-AdhesionofUropathogenicEscherichiacoliintheRatKidneyDuringPregnancy(AcceptedPosterPresentation).94thAnnualMeetingoftheAmericanSocietyforMicrobiology,LasVegas,NV;5/1994.

38. PhamT,HartA,GoluszkoP,KaulA,MartensM,NowickiSandNowicki

B.IdentificationandCharacterizationofLigandsforDrandRelatedXAdhesinsinEscherichiacoliAssociatedwithGestationalPyelonephritis(PosterPresentation).94thAnnualMeetingoftheAmericanSocietyforMicrobiology,LasVegas,NV;5/1994.

39. NowickiS,NowickiB,MartensM.GonococcalInfectioninNon-Human

HostisDeterminedbyHumanFactorC1q(SlidePresentation).AmericanSocietyofMicrobiologyGeneralMeeting,LasVegas,NV;5/1994.

40. NowickiB,YallampalliC,KaulA,NowickiS,HartA.RoleofNitricOxide

(NO)inExperimentalUrogenitalInfections.AnnualMeetingofInfectiousDiseaseSocietyforObstetricsandGynecology,Monterey,CA;8/1994.

41. NowickiB,GoluszkoP,KaulA,MoseleyS,NowickiS.DevelopmentofExperimentalChronicPyelonephritiswithDrFimbriaeBearingEscherichiacoli075:K5:H-1995InterstitialCystitisSymposium;10/1994.

42. NowickiS,RamP,MorseS,KaulA,PhamT,RamS,Goluszkoand

NowickiBJ.DifferentiationbetweenGonococcalPIDandLocalIsolatesonAnimalModel.(PosterPresentation).AmericanSocietyofMicrobiologyGeneralMeeting.Washington,DC;5/1995.

43. KaulA,NowickiS,YallampalliC,andNowickiB.InhibitionofNitricOxide

inExperimentalModelofPyelonephritisReducesHostResistancetoEscherichiacoliRenalInfectionandIncreasesDisseminationtotheUterusandLiver.95thGeneralMeetingASM.Washington,DC;5/1995.

44. KaulA,GoluszkoP,PhamT,MoseleyS,NowickiS,NowickiB.Renal

ColonizationandLethalOutcomeinSCIDMicebyUropathogenicEscherichiacolianditsPreventionbyMutationintheDrpiliCodingRegion.9thInternationalCongressofImmunology.SanFrancisco,CA;7/1995.

45. NowickiS,RamS,RamPandNowickiB.ParadoxicalEffectof

ComplementC1qonGonococci:ProtectionVersusDamage.9thInternationalCongressofImmunology(PosterPresentation).SanFrancisco,CA;7/1995.

46. NowickiS,RamP,RamS,NowickiBJ.ExperimentalGonococcalInfection

CausedbyPIDIsolatesisPreventedbyAnti-C1q-Antibodies.(PosterPresentation).InfectiousDiseasesSocietyforObstetricsandGynecologyMeeting.GrandTraverse,MI;8/1995.

47. NowickiB,YallampalliC,KaulA,NowickiS.InhibitionofNitricOxide

ReducesHostResistancetoEscherichiacoliInfectionandIncreasesDisseminationinExperimentalPyelonephritis.InfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG).TraverseCity,MI;8/1995.

48. YallampalliC,KaulA,NowickiS,NowickiB.FetalGrowthArrestInducedbySynergisticEffectsofInfectionandL-NAME.InfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG).TraverseCity,MI;8/1995.

49. RamP,NowickiS,MorseS,RamS,andNowickiB.SerumBactericidal

ResistanceofClinicalGonococcalIsolatesisLinkedtothePresenceofa344BasePairDNAFragmentofsac-4.11thMeetingoftheInternationalSocietyforSTDResearch(PosterPresentation).NewOrleans,LA;8/1995.

50. NowickiS,RamP,RamS,PhamT,NowickiB.C1qDependentVirulence

ofGonococciisDeterminedbyDNAFragmentConferringSerumBactericidalResistance(PosterPresentation).NewOrleans,LA;8/271995-8/30/1995.

51. NowickiB,ManickaratnamM,HillierS,andNowickiS.Characterization

ofEscherichiacoliVirulenceFactorsfromGenitalTractInfectionDuringPregnancy.IVWorldCongress,ESIDOG,Marbella,Spain;10/29/1995-11/5/1995.

52. PhamT,GoluszkoP,SelvaranganR,NowickiS,andNowickiB.Cloning

andMolecularCharacterizationofaNovelDra-RelatedPyelonephritis-AssociatedEscherichiacoliAdhesin.96thASM,NewOrleans,LA;5/1996.

53. NowickiS,RamP.SkarpetowskiA,PhamTandNowickiB.Identification

ofsac-4MutationsthatEffectVirulenceofGonococcalPIDStrains.InfectiousDiseasesSocietyforObstetricsandGynecology.BeaverCreek,CO;8/1996.

54. NowickiS,RamP,SkarpetowskiAandNowickiB.ARecombinant

MoleculeofNeisseriaGonorrhoeaethatConfersC1qDependentVirulenceinExperimentalAnimals.10thInternationalPathogenicNeisseriaConference,Baltimore,MD;9/1996.

55. NowickiB,FangL,SinghalJ,NowickiSandYallampalliC.LethalOutcomeofUterineInfectioninPregnantButNotinNonpregnantRatsandIncreasedDeathRatewithInhibitionofNitricOxide(OralPresentation).Forty-fourthAnnualScientificMeeting;SocietyforGynecologicInvestigation,SanDiego,CA;3/1997.

56. SelvaranganR,PhamT,GoluszkoP,MathewsonJJ,NowickiS,and

NowickiB.MolecularCharacterizationofReceptorSiteSpecificitiesAmongDiarrhealStrainsofE.coliExpressingDrFamilyofAdhesins.97thGeneralMeetingoftheAmericanSocietyforMicrobiology.Miami,FL;5/1997.

57. GoluszkoP,PopovV,SelvaranganR,NowickiS,PhamT,andNowickiB.

DepolymerizationofMicrotubulesPreventDecayAcceleratingFactor-DrfimbriaeMediatedInternalizationoftheRecombinantEscherichiacoliintoHELACells.97thGeneralMeetingoftheAmericanSocietyforMicrobiology.Miami,FL;5/1997.

58. NowickiB,FangL,SinghalJ,NowickiS.TheRoleofDraOperonand

NitricOxideinEscherichiacoliUterineInfectioninPregnantRats.24thInfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG),LasCorabas,PuertoRico;8/1997.

59. NowickiSandNowickiB.ExperimentalmodelofNeonatalGonococcal

Infection,TransmissionofN.GonorrhoeaefromPregnantMothertotheFetusisC1qDependent.24thInfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG),LasCorabas,PuertoRico;8/1997.

60. NowickiS,PhamT,SelvaranganR,GoluszkoP,HartAandNowickiB.

PotentialRoleofComplementClqinGonococcalPelvicInflammatoryDisease.TexasImmunologyConference,Galveston,TX;11/1997.

61. SelvaranganR,GoluszkoP,PopovV,SinghalJ,LublinD,PhamT,Nowicki

SandNowickiB.Humandecay-acceleratingfactor(CD55),andDrFimbriaeInteractionMediateInvasionofEscherichiacoliinaRecombinantModelofCell-CellInteraction.McLaughlinColloquium,Galveston,TX;3/1998.

62. ScanksK,VanTassellA,andNowickiS.NeisseriaGonorrhoeaeSuffers

fromPreMenstrualSyndrome.SummerResearchSymposium,Galveston,TX;7/1998.

63. NowickiS,HartA,AndersonGD,andNowickiB.NonRandom

AssociationofNeisseriaGonorrhoeaeandChlamydiaTrachomatisinGenitalInfection.AnnualMeetingoftheInfectiousDiseasesSocietyforObstetricsandGynecology,JacksonHole,WY;8/1998.

64. HartA,NowickiS,NguyenK,AndersonG,andNowickiBJ.

NephropathogenicEscherichiacoliVirulenceFactorsandAssociationwithAmpicillinResistanceduringPregnancy.Presentedatthe98thAmericanSocietyofMicrobiologyGeneralMeeting,Atlanta,GA;5/1998.

65. NowickiS,SelvaranganR,AndersonGD,andNowickiB.Experimental

TransmissionofNeisseriaGonorrhoeaefromPregnantRattotheFetus.EleventhInternationalPathogenicNeisseriaConference,Nice,France;11/1998.

66. NowickiS,HartA,AndersonGD,PeytonC,TurnerB,andNowickiB.

RelationshipbetweenChlamydialCo-infectionandClqDependentSerumResistanceofNeisseriaGonorrhoeae.EleventhInternationalPathogenicNeisseriaConference,Nice,France;11/1998.

67. SelvaranganR,GoluszkoP,PopovV,PhamT,NowickiSandNowickiB.

ContributionofDecayAcceleratingFactorDomainstoInternalizationofPathogenicEscherichiacoliExpressingDrAdhesins.10thInternationalCongressofImmunology,NewDelhi,India;11/1998.

68. McConleyS,LamptonA,HartA,NowickiB,andNowickiS.Differencesin

BindingofNormalHumanSerumAntibodiestoNeisseriaGonorrhoeaeDuringtheMenstrualCycle.SummerResearchSymposium,Galveston,TX;1999.

69. LamptonA,McConleyS,HartA,NowickiB,andNowickiS.TheEffecton

NeisseriaGonorrhoeaeofChangesInComplementActivityofNormal

HumanSerumDuringtheMenstrualCycle.SummerResearchSymposium,Galveston,TX;1999.

70. Hart-VanTassellA,NguyenK,NowickiS,NowickiB.BactericidalActivity

ofSerumAgainstNeisseriaGonorrhoeaeisAffectedbytheMenstrualCycle.99thGeneralMeetingoftheAmericanSocietyforMicrobiology;1999.

71. HasanR,UrvilP,SinghalJ,GoluszkoP,NowickiS,NowickiB.Mutations

ofAminoAcidsonDecayAcceleratingFactor(DAF)thatAffectBindingandInvasionofUropathogenicEscherichiacoliBearingDrAdhesins”.99thGeneralMeetingoftheAmericanSocietyforMicrobiology;1999.

72. HasanR,UrvilP,PawelczykE,GoluszkoP,NowickiS,NowickiB.

DissectingtheRoleofDecayAcceleratingFactor(DAF)asaBacterialReceptorandRegulatorofComplement.100thGeneralMeetingAmericanSocietyforMicrobiology;5/2000.

73. SelvaranganR,GoluszkoP,SinghalJ,CarnoyC,MoseleyS,HudsonB,

NowickiS,NowickiB.TypeIVCollagenBindingPhenotypeofDrFimbriatedEscherichiacoliisEssentialforExperimentalChronicPyelonephritis.100thGeneralMeetingAmericanSocietyforMicrobiology;5/2000.

74. Hart-TassellAR,LamptonA,McConleyS,NowickiBJ,NowickiS.Changes

inComplementActivityofSerumDuringtheMenstrualCycle:APossibleRoleinGonococcalPID.100thGeneralMeetingAmericanSocietyforMicrobiology;5/2000.

75. NowickiB,NowickiS,HasanR,YoungS,NagamaniM,PhamT.

ExpressionofDecayAcceleratingFactor(DAF)inEndometrialAdenocarcinomaisInverselyRelatedtotheStageoftheTumor.47thAnnualScientificMeetingoftheSocietyforGynecologicInvestigation.Chicago,IL;3/2000.

76. SelvaranganR,GoluszkoP,SinghalJ,NowickiS,NowickiBColchicine

PreventsAscendingUrogenitalInfectionofInvasiveDrfimbriated

EscherichiacoliinPregnantRats.47thAnnualScientificMeetingoftheSocietyforGynecologicInvestigation,Chicago,IL;3/2000.

77. NguyenK,HartA,UrvilP,NowickiB,NowickiS.ANovelGenein

NeisseriaGonorrhoeaeStrainsCausingPelvicInflammatoryDisease.100thGeneralMeetingAmericanSocietyforMicrobiology;2000.

78. NowickiS,HartVan-TassellA,NowickiB.ChangesinSerumAcrossthe

MenstrualCycle-istheriskfactorforGonococcalPID?2000AnnualMeetingoftheInfectiousDiseasesSocietyforObstetricsandGynecology;2000.

79. GoluszkoP,SinghalJ,NowickiS,NowickiB.ColchicinePrevents

AscendingUrogenitalInfectionofInvasiveDrFimbriatedEscherichiacoliinPregnantRats.2000AnnualMeetingoftheInfectiousDiseasesSocietyforObstetricsandGynecology;2000.

80. NowickiS,NguyenK,HartA,NowickiBandUrvilP.RoleofComplement

inSexuallyTransmittedDisease(STD),14thEuropeanImmunologyMeeting,Poznan,Poland;2000.

81. NowickiB,HasanRJ,UrvilPT,PawelczykE,GoluszkoP,NowickiS.

DissectingtheRoleofDecayAcceleratingFactor(DAF)asaBacterialReceptorandRegulatorofComplement,14thEuropeanImmunologyMeeting,Poznan,Poland;2000.

82. NowickiS,Hart-VanTassellA,PawelczykE,SparlingF.Gonococcal

Transferrin-bindingProteinsareEssentialforExperimentalBacteremia,12thInternationalPathogenicNeisseriaConference,Galveston,TX,PosterAward;11/2000.

83. SelvaranganR,GoluszkoP,SinghalJ,CarnoyC,MoseleyS,HudsonB,

NowickiS,NowickiBJ.PointMutationinEscherichiacoliDrFimbriaeAbolishesTypeIVCollagen-BindingandRenalPersistenceinExperimentalChronicPyelonephritis.2001AnnualScientificMeetingoftheInfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG),QuebecCity,Canada;8/2001.

84. HartA,UrvilP,NowickiB,andNowickiS.SerumComplementActivity

DuringMensesasaRiskFactorforGonococcalPelvicInflammatoryDisease.2001AnnualScientificMeetingoftheInfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG),QuebecCity,Canada;8/2001.

85. HartA,NowickiBJ,ReisnerB,PawelczykE,GoluszkoP,UrvilP,Anderson

G,andNowickiS,Ampicillin-ResistantEscherichiacoliinGestationalPyelonephritis:IncreasedOccurrenceandAssociationwiththeColonizationFactorDrAdhesin.2001AnnualScientificMeetingoftheInfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG),QuebecCity,Canada;8/2001.

86. HoldMD,NowickiS,HartVan-TassellA,UrvilPandNowickiBJ.Serum

ResistanceofNeisseriagonorrhoeaeisDiminishedbyPointMutationsinthePIDGene.LifeScienceSymposium,UTMB,Galveston,TX,AbstractAward;5/2002.

87. NowickiB,YallampalliU,NowickiS,YallampalliC.DefenseMechanisms

AgainstGBSInfectioninPregnantRatInvolvesNitricOxide.InfectiousDiseasesSocietyforObstetricsandGynecologyConference,Banff,Calgary,Canada;8/2002.

88. NowickiS,UrvilPT,NguyenK,DasM,HoldMandNowickiBJ.

PathogenicityIslandaNewTargetforGonococcalVaccine.13thInternationalPathogenicNeisseriaConference,OsloNorway;9/2002.

89. NowickiB,PawelczykE,HartA,HankinsG,AndersonG,LocksmithG,

OlsonGL,NowickiS.MaternalChangesinTollLikeReceptor4inPeripheralBloodLeukocytes;AssociationwithPretermLabor.SocietyforGynecologicInvestigation,Washington,DC;3/2003.

90. PawelczykE,NowickiS,Hart-VanTassellA,GoluszkoP,HankinsG,AndersonG,LocksmithG,OlsonGL,NowickiB.PregnancyisAssociatedwithLowExpressionofToll-likeReceptor4mRNAinPeripheralBlood

Leukocytes;RegulationbyPregesteroneand17ß–estradiol.SocietyforGynecologicInvestigation,Washington,DC;3/2003.

91. NowickiS,Hart-VanTassellA,UrvilP,AndersonG,andNowickiB.

ChangesinSerumComplementDuringMensesandSusceptibilitytoGonococcalPelvicInflammatoryDisease.SocietyforGynecologicInvestigation,Washington,DC;3/2003.

92. YallampalliC,NowickiS,YallampalliU,Nowicki,B.FetalGrowth

RestrictionandSeverityofInfectioninPregnantRatsUponIntrauterineInfectionwithGroupBStreptococcusandE.coliisIncreasedwithNitricOxideInhibition.SocietyforGynecologicInvestigation,Washington,DC;3/2003.

93. NowickiS,Hart-VanTassellA.,UrvilP.,NowickiB.GenderSpecificRisk

FactorforComplicatedGonococcalInfections.InfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG);4/2003.

94. MotsenbockerEB,PawelczykE,NowickiS,GoluszkoP,UrvilP,HartA,

NowickiBJ.Toll-LikeReceptor4ExpressioninRatPregnancyanditsRegulation.InfectiousDiseasesSocietyforObstetricsandGynecology(IDSOG);4/2003.

95. YallampalliU,ChauhanM,Hart-VanTassellA,NowickiS,NowickiB,

YallampalliC.NitricOxideAttenuatesExpressionofDecayAcceleratingFactor(DAF)andInhibitsDR+E.coliBindinginTrophoblastCells.SocietyforGynecologicInvestigation,Houston,TX;3/2004.

96. NowickiB,PawelczykE,HankinsGD,NowickiS.IsTLR4aRiskFactorfor

RacialDisparityinPretermLabor?SocietyforGynecologicInvestigation,Houston,TX;3/2004.

97. ChumakovS,NowickiBJ,NowickiS."EvolutionoftheNeisserialSpecies"

TexasBranchoftheAmericanSocietyforMicrobiologyFallMeeting,Houston,TX;2004.

98. PawelczykE,NowickiS,HankinsGD,GoluszkoP,PladzykR,HartVanTassellA,AndersonGD,NowickiB.PretermLaborandIncreasedExpressionofToll-likeReceptor4:DifferencesinReceptorDensityinMaternalMonocytes.SocietyforGynecologicInvestigation,Houston,TX;3/2004.

99. PutontiC,Hart-VanTassellA,UrvilP,ZhangM,LuoY,ChumakovS,

NowickiS,NowickiB,FofanovY.IdentificationofRegionsofUnusualStatisticalPropertieswithinGenomicSequences.The2003AnnualResearchConference,W.M.KeckCenterforComputationalandStructuralBiology,andHoustonAreaMolecularBiophysicsProgram,ClearLake,Texas;2004.

100. PutontiCHartA,UrvilP,ZhangM,FofanovY,Hart-VanTassellA,UrvilP,

NowickiBJ,NowickiS,PilotStudyonGenderSpecificRaceFactorsforComplicatedGonococcalInfections:Part1ChangesinSerumC1qLevelsacrossMenstrualCycleTexasBranchoftheAmericanSocietyforMicrobiologyFallMeeting,Houston,TX;2004.

101. Wroblewska-SeniukK,NowickiS,NowickiBJ,YallampalliCTheRoleOf

E.coliVirulenceFactorsinGestationalIntrauterineInfectionTexasBranchoftheAmericanSocietyforMicrobiologyFallMeeting,Houston,TX;2004.

102. Hart-VanTassellA,UrvilP,NowickiBJ,Nowicki,S“PilotStudyon

GenderSpecificRaceFactorsforComplicatedGonococcalInfections:Part1ChangesinSerumC1qLevelsAcrossMenstrualCycleTexasBranchoftheAmericanSocietyforMicrobiologyFallMeeting,Houston,TX;2004.

103. Wroblewska-SeniukK,NowickiS,NowickiBJ,YallampalliC.TheRoleof

E.coliVirulenceFactorsinGestationalIntrauterineInfectionTexasBranchoftheAmericanSocietyforMicrobiologyFallMeeting,Houston,TX;2004.

104. Wroblewska-SeniukK,NowickiS,LeBouguenecC,NowickiBJ,YallampalliC.TheRoleofDr/AFAFimbriaeofE.coliandNitricOxideinIntrauterineGestationalInfectionSGIAnnualMeeting;2005.

105. PawelczykE,SoloffM,NowickiB,NowickiS.GlucocorticoidReceptor-

MediatedDownRegulationofTLR4–AHostMechanismofControllingImmuneResponsesDuringPregnancy,SGIAnnualMeeting;2005.

106. NowickiS,HartA,PawelczykE,MontogmeryRiceV,andNowickiB.RacialDisparitiesinPretermLaborRoleofTLR-4.NationalLeadershipSummitonEliminatingRacialandEthnicDisparitiesinHealth,01/09/2006.

107. NowickiS,PachecoL,HartA,PawelczykE,MontogmeryRiceV,and

NowickiB.LaborinAfricanAmericanWomenisAssociatedwithLowLevelofCD55.SocietyforGynecologicInvestigationAnnualScientificMeeting,03/22/2006-03/25/2006.

108. NowickiB,CurranE,EstesM,HartA,MontgomeryRiceV,andNowicki

S.EstrogenIncreasesMenopausalHostSusceptibilitytoExperimentalAscendingUrinaryTractInfection.SocietyforGynecologicInvestigationAnnualScientificMeeting,03/22/2006-03/25/2006.

109. GoluszkoP,JonesA,PopovV,NowickiS,NowickiB,andYallampalliC.

TypeIaGroupBStreptococcusExploitsPI3K/AktSignalingPathwaytoInvadeHumanEndometrialCells.SocietyforGynecologicInvestigationAnnualScientificMeeting,03/22/2006-03/25/2006.

110. RobertsonK,WhittyJ,andNowickiS.IsFetalFibronectinintheFirst

TrimesteraUsefulScreenforPretermLabor?MeharryMedicalCollegeDepartmentofObstetricsandGynecology3rdAnnualResearchSymposium,04/06/2006.

111. NowickiS,PachecoL,HartA,PawelczykE,MontgomeryRiceV,Ladson

G,WhittyJ,andNowickiB.AmericanWomenisAssociatedwithLowLevelofCD55.MeharryMedicalCollegeDepartmentofObstetricsandGynecology3rdAnnualResearchSymposium,04/06/2006.

112. RiceJC,PengT,KuoY,PendyalaS,SimmonsL,BoughtonJ,IshiharaK,

NowickiS,andNowickiB.EscherichiaColithatCauseRenalTransplantPyelonephritisandAcuteAllograftInjuryExpressUniqueUropathogenicVirulenceFactors.TheWorldTransplantCongressmeeting07/2006.AbstractsprintedintheAmericanJournalofTransplantation.

113. NowickiS.InfectionandImmunityofCardiovascularDisease.JamesSymposium,04/2007(Nashville,TN)

114. NowickiS.PossibleMechanismofPTDinAfricanAmericanWomen.National MedicalAssociation.08/04-09/2007(Honolulu,HI).

115. Nowicki,S.PretermLaborasadisorderinitiatedbyinflammation:implicationforthetherapyofpregnantpatientswithhighrisk.XIIIBiotechnologySummerProgram,Gdańsk,Poland2007

116. NowickiS.DoesComplementMatterinWoman’sGenitalTract.26thAnnualMeetingoftheAmericanSocietyforReproductiveImmunology,06/15/2006–06/17/2006(Nashville,TN).

117. IzbanMG,NowickiB,NowickiS“BacterialEndotoxin-InducedStimulationofCD55ExpressionInMonocyticTHP-1CellsMimicsCD55expressionPatterninPTL.SGI;Glasgow03/2009

118. NowickiB,PawelczykE,IzbanMG,SoloffM,NowickiSRoleofSupra-physiologicConcentrationsofProgesteroneinDown-RegulationofTLR-4:ImplicationofProgesteroneTreatmentinPTL.SGI;Glasgow03/2009.

119. NowickiS,PawelczykE,IzbanMG,HeartA,OlsonG,NowickiB.ThePredictiveValueofCD55ExpressioninMaternalPWBC’sonPretermDelivery.SGI;Glasgow03/2009.

120. Bogdan J Nowicki, MD,PhD1, Rafia J Hasan, PhD3, Werner A

Braun, PhD4 and Stella Nowicki, DDS2. Gestational Pyelonephritis and the Structure-Function Analysis of E. coli Invasion to the Uroepitelium Oral Presentation SGI; Orlando April 2010

121. Stella Nowicki, DDS1, Siddharth Pratap, PhD1, Michael G Izban, PhD1 and Bogdan J Nowicki, MD, PhD1. Combine Use of Toll-Like

Receptor 4 and CD55 in Maternal Blood Monocytes as a Molecular Predictors for Preterm Labor and Delivery. Oral

Presentation SGI; Orlando o4/2010

122. Stella Nowicki and Bogdan Nowicki. Downregulation of TLR4 Receptor-New Immunosuppresive Transcriptional Target for

Glucocorticoid.; 3rdLatinAmericanCongressonAutoimmunityBuenosAires,July1-3,2010

123. Bogdan J. Nowicki, MD, PhD1,2 , Edyta Pawelczyk, PhD3, Michael G. Izban, Ph.D.2, Siddharth Pratap, Ph.D. 2, and Stella Nowicki, DDS1,2

Preterm Labor is Associated with an Increase in the Proinflammatory Signal Transducer TLR4 Receptor on Maternal Blood Monocytes-Novel Diagnostic Test. 1st Congress for Gynecology and Fertility-Israel-Poland

(GOFIP), June 10-12, 2011

124. Dr. Stella Nowicki, Dr. Rajbir Singh, Dr. Tanu Rana, Dr. Kevin Osteen, Dr. Barry Jarnagin and Dr. Bogdan Nowicki; Glucocorticoid and

CD55: Missing Link between Stress and Infertility. 1st Congress for Gynecology and Fertility-Israel-Poland (GOFIP), June 10-12, 2011

125. Nowicki B. 1 , Wroblewska-Seniuk K.2, Yallampalli C. 3 , Le Bouguénec C.4 and Nowicki S1; The role of nitric oxide in intrauterine

gestational infection caused by Dr/Afa positive E. coli 1st Congress for Gynecology and Fertility Israel-Poland (GOFIP), Warsaw, Poland,

June 10-12, 2011

126. Stella Nowicki, DDS1, Siddharth Pratap, PhD1, Michael G Izban, PhD1 and Bogdan J Nowicki. CD55 in Maternal Blood Monocytes as a

Molecular Predictor for Preterm Labor and Delivery. International Infectious Diseases Society for Obstetrics and Gynecology-USA

(IIDSOG-USA) 2011 Weill Cornell Medical College, NY May 6-8, 2011

127. BJ Nowicki, MD PhD; T Rana, PhD; R Singh, MD; S Nowicki, DDS; Identification of DAF Residues which facilitate intracellular multiplication

of Dr+ E. coli. 5th International Complement Therapeutics Conference, Rhodes, Greece, June22-27, 2011

128. S Nowicki, DDS; T Rana, PhD; R Singh, MD; BJ Nowicki, MD PhD; Dexametasone down-regulates DAF and decrease intracellular survival of

Dr+ E. coli. 5th International Complement Therapeutics Conference, Rhodes, Greece, June 22-27, 2011

129. Izban MG, Nowicki BJ, Nowicki S. Vitamin D3 promotes NF-κB-dependent expression of CD55 in monocytes. Poster Presentation 13th RCMI International Symposium on Health Disparities December 9-13,

2012, Puerto Rico.

130. Rana T, PhD; S Nowicki, DDS; R Singh, MD; BJ Nowicki, MD PhD

Identification of CD55 Residues that Facilitate Invasion & Intracellular Persistance of the Gestational Pathogen Dr+ E. coli 9th Annual JamesResearch Symposium at MMC 2012.

131. Tanu Rana, Stella Nowicki, Rajbir Singh, and Bogdan J. Nowicki.

Novel strategy for the non-antibiotic treatment of persistant intracellular infection: microtubule depolymerizing agents eliminate intracellular E. coli. Presented at 13th RCMI International Symposium on Health Disparities: December 9-13, 2012 in San Juan, Puerto Rico.

132. Tanu Rana, Stella Nowicki, Rajbir Singh, and Bogdan J. Nowicki. Chronic Pyelonephritis in Pregnancy: Intracellular Survival and Persistence of the Gestational Pathogen Dr+ E. coli. January 2012 SGI Annual Scientific Meeting.

133. Rajbir Singh, Tanu Rana, Bogdan J. Nowicki and Stella Nowicki.

Glucocorticoid And CD55: Missing Link Between Stress And Infertility 9th Annual James Research Symposium at MMC April 2012.

134. Stella Nowicki, Tanu Rana, Rajbir Singh, Bogdan Nowicki.

Glucocorticoid as a new therapeutic approach against invasive Dr + E. coli causing chronic pyelonephritis. Clinical and Scientific Advances in Urinary Tract Infections Conference, International Symposium May 31-June 2, 2013 At the Research Institute at Nationwide Children’s Hospital.

135. Tanu Rana, Rafia J Hasan, Stella Nowicki, Mathura S. Venkatarajan,

Rajbir Singh, Petri T Urvil, Vsevolod Popov, Werner A Braun, Waldemar Popik, J. Shawn Goodwin and Bogdan J. Nowicki Complement Protective Epitopes and CD55-Microtubule Complexes Facilitate the Invasion and Intracellular Persistence of Uropathogenic E. coli. Clinical and Scientific Advances in Urinary Tract Infections Conference, International Symposium May 31-June 2, 2013 At the Research Institute at Nationwide Children’s Hospital.